BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8895367)

  • 1. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system.
    Rocchi S; Tartare-Deckert S; Sawka-Verhelle D; Gamha A; van Obberghen E
    Endocrinology; 1996 Nov; 137(11):4944-52. PubMed ID: 8895367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential involvement of FRS2 in insulin signaling.
    Delahaye L; Rocchi S; Van Obberghen E
    Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
    Maile LA; Clemmons DR
    Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules.
    Rocchi S; Tartare-Deckert S; Murdaca J; Holgado-Madruga M; Wong AJ; Van Obberghen E
    Mol Endocrinol; 1998 Jul; 12(7):914-23. PubMed ID: 9658397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
    Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
    Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.
    Luo M; Reyna S; Wang L; Yi Z; Carroll C; Dong LQ; Langlais P; Weintraub ST; Mandarino LJ
    Endocrinology; 2005 Oct; 146(10):4410-6. PubMed ID: 16020478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexamining interaction of the SH2 domains of SYP and GAP with insulin and IGF-1 receptors in the two-hybrid system.
    Lamothe B; Bucchini D; Jami J; Joshi RL
    Gene; 1996 Dec; 182(1-2):77-80. PubMed ID: 8982070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA; Lienhard GE; Lavan BE
    Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.
    Mothe I; Delahaye L; Filloux C; Pons S; White MF; Van Obberghen E
    Mol Endocrinol; 1997 Dec; 11(13):1911-23. PubMed ID: 9415396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for embrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor.
    Ling Y; Maile LA; Clemmons DR
    Mol Endocrinol; 2003 Sep; 17(9):1824-33. PubMed ID: 12791772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.
    Zhao R; Zhao ZJ
    J Biol Chem; 2000 Feb; 275(8):5453-9. PubMed ID: 10681522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase.
    Rocchi S; Tartare-Deckert S; Mothe I; Van Obberghen E
    Endocrinology; 1995 Dec; 136(12):5291-7. PubMed ID: 7588273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
    Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
    Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
    Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
    Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.